Ion Beam ApplicationsIOBCF 82 Days Payable is 103.17 as of Dec. 2025, which is 19% above its 10-year median of 86.39. GuruFocus rates IOBCF with a GF Score™ of 82/100 and a GF Value™ of $18.71 (Fairly Valued). The stock has 10 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Ion Beam Applications ranks better than 61.26% on this metric.
The historical rank and industry rank for Ion Beam Applications's Days Payable or its related term are showing as below:
IOBCF'
s Days Payable Range Over the Past 10 Years
Min: 78.07 Med: 86.39 Max: 110.47
Current: 90.76
During the past 13 years, Ion Beam Applications's highest Days Payable was 110.47. The lowest was 78.07. And the median was 86.39.
IOBCF's Days Payable is ranked better than 61.26% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs IOBCF: 90.76
Ion Beam Applications Days Payable Historical Data
* Premium members only.
The historical data trend for Ion Beam Applications's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Ion Beam Applications's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ion Beam Applications Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's Days Payable distribution charts can be found below:
* The bar in red indicates where Ion Beam Applications's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Ion Beam Applications's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ion Beam Applications (IOBCF) has a Days Payable of 103.17 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ion Beam Applications and its competitors. This is 19% above median its historical median of 86.39. Over the past decade, Ion Beam Applications' Days Payable has ranged from 78.07 to 110.47. According to the industry distribution chart, Ion Beam Applications ranks #308 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 38.7%.
Is Ion Beam Applications' Days Payable too high?
Ion Beam Applications' current Days Payable of 103.17 is 19% above median its 10-year median of 86.39. Over the past 10 years, this metric has ranged from a low of 78.07 to a high of 110.47. The Medical Devices & Instruments industry median Days Payable is 67.87. Ion Beam Applications' value of 103.17 is 52% above this industry median. Based on the distribution chart, Ion Beam Applications ranks #308 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ion Beam Applications has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ion Beam Applications' Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ion Beam Applications ranks #308 out of 795 companies for Days Payable. This puts Ion Beam Applications in the upper half of its industry. The industry median Days Payable is 67.87. Ion Beam Applications' value of 103.17 is 52% above this benchmark. Historically, Ion Beam Applications' own Days Payable has ranged from 78.07 to 110.47 over the past decade. While the company's 10-year median is 86.39 vs. the industry median of 67.87, Ion Beam Applications has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ion Beam Applications's current Days Payable of 103.17 is 52% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ion Beam Applications and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ion Beam Applications's current Days Payable is 103.17, which is 19% above median its own 10-year median of 86.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ion Beam Applications stock overvalued right now?
Based on GuruFocus' analysis, Ion Beam Applications (IOBCF) is currently considered Fairly Valued. The stock's GF Value™ is $18.71, compared to a current price of $18.50 — trading 1.1% below its estimated fair value. The current Days Payable is 103.17, which is 19% above median its 10-year median of 86.39 and 52% above the Medical Devices & Instruments industry median of 67.87. Ion Beam Applications' overall GF Score™ is 82/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ion Beam Applications (IOBCF), the current Days Payable is 103.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ion Beam Applications (IOBCF) Overvalued in 2026?
Based on GuruFocus' analysis, Ion Beam Applications stock appears to be undervalued.
The current stock price of $18.50 is trading 1.1% below its estimated GF Value™ of $18.71.
GuruFocus considers Ion Beam Applications to be Fairly Valued.
Key valuation signals for IOBCF:
Days Payable: 103.17 (19% above median its 10-year median of 86.39)
GF Value™: $18.71 vs. price of $18.50 (1.1% below fair value)
Industry Position: 52% above the Medical Devices & Instruments median (#308 of 795)
No single metric tells the full story. See the IOBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
82GF Score
Get the complete analysis for IOBCF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOBCF has been successfully added to your 
